Point your AI agent at freehire and let it find you a job.

Get the CLI →

Halozyme

Develops technologies for subcutaneous delivery of biopharmaceutical drugs.

H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
Discussion
biotechhealth-techhealthcarepharmaceuticals

Company facts

Founded
1998
Employees
423
Headquarters
United States
CEO
Helen Torley
Type
Public
Listed
NASDAQ: HALO
Subsidiaries
Halozyme Hypercon, Antares Pharma, Surf Bio

About

Halozyme Therapeutics is a biotechnology company that focuses on the development and commercialization of innovative therapies for human health. Founded with the vision to enhance the effectiveness of therapies by improving the delivery and absorption of drugs, Halozyme has made significant contributions to the field of therapeutics. Their proprietary product, Hylenex, is an enzyme that facilitates the distribution and absorption of injected drugs, thereby improving patient outcomes. The company is also well-known for its collaboration with major pharmaceutical companies, leveraging its ENHANZE drug delivery technology to enhance the performance of biologics. With a commitment to research and development, Halozyme continues to explore new treatments for various diseases, solidifying its position in the biotechnology industry as a leader in drug delivery solutions.

9 jobs

Tailor your CV for this role?

We couldn't check your fit for this role — add a CV to your profile to see it next time.

A new version of freehire is available